Profile
SYBX NVO VRTX REGN MRNA SGEN
Company Name Synlogic, Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Moderna, Inc. Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $19.55M $575.53B $127.80B $116.89B $46.80B $43.15B
Employees 0.01K 66.02K 5.40K 13.68K 5.60K 3.26K
CEO Mr. Antoine Awad Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. Stephane Bancel Mr. David R. Epstein B.Sc., M.B.A.
Ratings
SYBX NVO VRTX REGN MRNA SGEN
Quant Rating Score 2 3 4 4 1 3
Quant Rating Sell Neutral Buy Buy Strong Sell Neutral
Trading
SYBX NVO VRTX REGN MRNA SGEN
Last Close $1.67 $126.73 $495.26 $1078.63 $122.11 $228.74
High 52 $4.78 $199.54 $495.91 $1100.05 $166.61 $228.9
Low 52 $0.25 $87.78 $340.48 $732.12 $69.51 $191.57
Price vs. 52 Week High -65.06 % -36.49 % -0.13 % -1.95 % -26.71 % -0.07 %
Price vs. 52 Week Low 568 % 44.37 % 45.46 % 47.33 % 75.67 % 19.4 %
Total Return
SYBX NVO VRTX REGN MRNA SGEN
1 Month Return 7.74 % -12.29 % 4.81 % 2.64 % 0.77 % 0 %
3 Month Return -10.7 % -0.09 % 24.6 % 22.13 % 13.1 % 0 %
6 Month Return -53.61 % 17.27 % 15.13 % 14.74 % 19.94 % 0 %
9 Month Return -10.22 % 35.54 % 39.4 % 39.15 % 69.81 % 6.59 %
YTD Return -56.62 % 22.5 % 21.72 % 22.81 % 22.79 % 0 %
1 Year Return 247.92 % -19.11 % 41.65 % 44.85 % 3.04 % 19.4 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SYBX NVO VRTX REGN MRNA SGEN
Dividend Yield Percentage (TTM) - 0.16 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -97.74 % 1.1 % 8.49 % 6.2 % -3.65 % -3.35 %
Dividend Per Share (TTM) - 0.2 % - - - -
Payout Ratio (TTM) - 47.03 % - - - -
Growth
SYBX NVO VRTX REGN MRNA SGEN
Asset Growth -31.85 % 30.35 % 25.23 % 13.23 % -28.74 % -1.21 %
Gross Profit Growth 57.14 % 32.32 % 9.25 % 6.49 % -85.12 % 22.93 %
Revenue Growth 185.68 % 31.26 % 10.17 % 7.76 % -64.94 % 24.65 %
Revenue 3 Year 127.26 % 90.51 % 59.87 % 55.67 % 2356.27 % 91.84 %
Revenue 5 Year -67.24 % 124.2 % 218.58 % 110.3 % 1070.62 % 215.48 %
Revenue 10 Year - 66.11 % 608.27 % 549.62 % 6447.35 % 494.04 %
EBIT Growth 18.18 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Net Income Growth 11.7 % 50.71 % 8.96 % -8.87 % -156.37 % 9.51 %
Net Income 3 Yeari Growth Per Share 62.77 % 106.79 % 34.59 % 13.48 % -529.9 % -764.83 %
Net Income 5 Yeari Growth Per Share 71.04 % 133.86 % 70.33 % 74.02 % -160.17 % -276.93 %
Net Income 10 Yeari Growth Per Share -55.07 % 98.61 % 809.6 % 871.12 % -2046.03 % -624.16 %
Operating Income Growth 18.18 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Operating Cash Flow Growth (CFG) 9.27 % 38.06 % -14.35 % -8.39 % -162.6 % 9.07 %
Operating 3 Year CFG 52.05 % 118.29 % 9.63 % 76.95 % -253.56 % -148.34 %
Operating 5 Year CFG 70.24 % 163.51 % 174.78 % 125.17 % -100.11 % -195.86 %
Operating 10 Year CFG -38.43 % 150.92 % 6084.35 % 713.56 % -4698.89 % -2622.09 %
EPS Growth 35.08 % 52.28 % 8.33 % -8.54 % -158.15 % 10.81 %
EPS Diluted Growth 35.08 % 52.37 % 8.35 % -9.03 % -161.39 % 10.81 %
Book Value Per Share -62.03 % 29 % 25.58 % 15.03 % -25.28 % -9.83 %
Share Holder 3 Year Equity Growth Per Share -86.39 % 75.22 % 104.06 % 137.56 % 439.94 % 33.92 %
Share Holder 5 Year Equity Growth Per Share -91.58 % 121.9 % 291.14 % 219.1 % 92.24 % 220.81 %
Share Holder 10 Year Equity Growth Per Share 124.84 % 49.62 % 1030.79 % 1286.9 % 1519.81 % 691.19 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - 80.03 % - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth -14.89 % 4.74 % 44.1 % 0.06 % 3.58 % -23.28 %
Free Cash Flow Growth 10.05 % 9.17 % -16.47 % -17.11 % -183.5 % 3.67 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022
Profitability
SYBX NVO VRTX REGN MRNA SGEN
Gross Profit Margin TTM -62.4 % 84.65 % 86.86 % 87.16 % 21.77 % 75.4 %
Return on Assets TTM -203.08 % 29.87 % 16.81 % 11.22 % -35.67 % -20.64 %
Return on Equity TTM -190 % 91.82 % 23.61 % 15.15 % -41.83 % -28.06 %
Return on Capital Employed TTM -196.97 % 82.5 % 20.67 % 12.53 % -35.81 % -29.5 %
Net Income Per EBT TTM 100.02 % 79.81 % 84.31 % 95.44 % 124.28 % 101.53 %
EBT Per Ebit TTM 147.98 % 101.7 % 114.62 % 104.74 % 93.44 % 93.47 %
EBIT Per Revenue TTM -1543.65 % 45.03 % 40.85 % 29.46 % -99.69 % -34.37 %
Cash Flow To Debt Ratio TTM -314.89 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Receivables Turnover TTM - 3.87 5.68 2.51 13.32 3.64
Payables Turnover TTM 7.24 2.88 3.81 2.51 22.04 2.52
Inventory Turnover TTM - 1.12 1.65 0.62 13.67 1.07
Fixed Asset Turnover TTM - 248.64 % 685.31 % 310.02 % 186.78 % 471.71 %
Asset Turnover TTM 8.89 % 81.71 % 42.57 % 38.12 % 30.81 % 63.3 %
Operating Cash Flow Per Share TTM -3.75 20.95 15.27 43.96 -7.54 -2.87
Free Cash Flow Per Share TTM -3.79 11.28 13.48 36.87 -9.61 -3.73
Cash Per Share TTM 266.34 % 208.61 % 3939.31 % 9758.35 % 2235.6 % 657.5 %
Operating Cash Flow Sales Ratio TTM -1421.06 % 38.24 % 38.74 % 36.17 % -55.91 % -23.48 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.02 % 53.85 % 88.22 % 83.87 % 127.41 % 129.82 %
Cash Flow Coverage Ratios TTM -314.89 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Price To Free Cash Flows Ratio TTM -0.42 78.64 36.73 29.41 -12.74 -61.54
Price To Operating Cash Flows Ratio TTM -0.44 41.59 32.42 24.54 -16.19 -79.67
Price Cash Flow Ratio TTM -0.44 41.59 32.42 24.54 -16.19 -79.67
Income Statement (TTM)
SYBX NVO VRTX REGN MRNA SGEN
Revenue $0B $232.26B $9.84B $13.12B $6.75B $1.96B
Gross Profit $-0B $196.5B $8.58B $11.3B $2.06B $1.55B
Gross Profit Ratio -57.08% 84.6% 87.17% 86.16% 30.52% 79.1%
EBITDA $-0.05B $112.94B $3.93B $5.13B $-3.21B $-0.62B
Net Income $-0.06B $83.68B $3.62B $3.95B $-4.71B $-0.61B
EPS Diluted -8.81 18.62 13.89 34.77 -12.34 -3.3
Balance Sheet (MRQ)
SYBX NVO VRTX REGN MRNA SGEN
Long Term Debt $0.01B $20.53B $0.72B $2.7B $1.22B $0.04B
Total Liabilities $0.03B $207.93B $5.15B $7.11B $4.57B $0.87B
Total Equity $0.04B $106.56B $17.58B $25.97B $13.85B $2.8B
Total Investments $0.02B $17.5B $3.45B $13.51B $4.68B $1.42B
Total Debt $0.02B $27.01B $0.81B $2.7B $1.24B $0.04B
Total Assets $0.08B $314.49B $22.73B $33.08B $18.43B $3.67B
Cash Flow Statement (TTM)
SYBX NVO VRTX REGN MRNA SGEN
Net Income $-0.06B $83.68B $3.62B $3.95B $-4.71B $-0.61B
Inventory $0B $-7.42B $-0.32B $-0.27B $0.75B $-0.23B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.05B $108.91B $3.54B $4.59B $-3.12B $-0.45B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.71B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.58
ABCL AbCellera Biologics Inc. 3.26
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.1
ABIO ARCA biopharma, Inc. 3.14
ABOS Acumen Pharmaceuticals, Inc. 3.48
ABSI Absci Corporation 4.48
ABUS Arbutus Biopharma Corporation 3.9
ABVC ABVC BioPharma, Inc. 0.7489
ABVX Abivax SA American Depositary Shares 11.86
ACAD ACADIA Pharmaceuticals Inc. 19.14
ACER Acer Therapeutics Inc. 0.9
ACET Adicet Bio, Inc. 1.59
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.8288
ACHV Achieve Life Sciences, Inc. 4.925
ACIU AC Immune SA 3.91
ACLX Arcellx, Inc. 64.41
ACRV Acrivon Therapeutics, Inc. Common Stock 8.86
ACST Acasti Pharma Inc. 2.76
ETFs With Exposure to SYBX
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 269.69
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 119.77
VXF Vanguard Extended Market Index Fund 0 178.79
IWC iShares Micro-Cap ETF 0.00835 129.27
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 93.5
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 93.48
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 47.88
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 47.88
VBINX Vanguard Balanced Index Fund Investor Shares 0 47.88
DFAU Dimensional US Core Equity Market ETF 0 37.89
DFAT Dimensional U.S. Targeted Value ETF 0.000155 56.79
VTSAX Vanguard Total Stock Market Index Fund 0 131.27
INNO Harbor Disruptive Innovation ETF 0 15.15
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 135.6
VITSX Vanguard Total Stock Market Index Fund 0 131.29
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000630922 92.7
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 135.6
DFQTX DFA U.S. Core Equity 2 Portfolio 0 36.88
VEMPX Vanguard Extended Market Index InstlPlus 0 334.63
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 246.27
Unlock